Benet to receive ISSX North American Scientific Achievement Award

UCSF School of Pharmacy faculty member Leslie Benet, PhD, has been named the 2015 recipient of the North American Scientific Achievement Award, presented by the International Society for the Study of Xenobiotics (ISSX).

The award recognizes Benet’s long-standing leadership in discovering key principles related to drug metabolism and transport in the body, also known as pharmacokinetics, which has made him one of the most highly cited pharmacologists worldwide. The award is in honor of the late Ronald W. Estabrook, PhD, the renowned biochemist who pioneered research into key drug-metabolizing enzymes.

The award, sponsored by XenoTech Inc., will be presented at the 20th North American ISSX Meeting on October 19, 2015 in Orlando, Florida, during a session where Benet will also deliver a lecture. Washington, D.C.-based ISSX is an international association of scientists that promotes the understanding of the interactions of medicines and chemicals with living systems and conducts scientific meetings worldwide.

“Les is a passionate researcher whose work has opened up new fields of inquiry,” wrote School faculty member Kathy Giacomini, PhD, in her nomination letter. “The conceptual advances he has made have been strong and at times paradigm shifting.”

Benet is a faculty member in the Department of Bioengineering and Therapeutic Sciences, a joint department of the UCSF Schools of Pharmacy and Medicine. He has been a member of the School faculty since 1969 and chaired the department (then named Biopharmaceutical Sciences) for two decades.


[Leslie Z. Benet Named 2015 North American Scientific Achievement Award Recipient][link defunct]


School of Pharmacy, Department of Pharmaceutical Chemistry, Department of Bioengineering and Therapeutic Sciences, PharmD Degree Program, Pharmaceutical Sciences and Pharmacogenomics Graduate Program (PSPG), PSPG

About the School: The UCSF School of Pharmacy aims to solve the most pressing health care problems and strives to ensure that each patient receives the safest, most effective treatments. Our discoveries seed the development of novel therapies, and our researchers consistently lead the nation in NIH funding. The School’s doctor of pharmacy (PharmD) degree program, with its unique emphasis on scientific thinking, prepares students to be critical thinkers and leaders in their field.